Switch theme
Sign up to access all valuation multiples
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company that engages in pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes, and related complications. Its products include drug series, chemical drugs, Chinese medicine series, and health products.
2001
n/a
LTM Revenue $1.2B
LTM EBITDA $72.2M
$3.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shijiazhuang Yiling has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $72.2M.
In the most recent fiscal year, Shijiazhuang Yiling achieved revenue of $1.4B and an EBITDA of $313M.
Shijiazhuang Yiling expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shijiazhuang Yiling valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.2B | XXX | XXX | XXX |
| Gross Profit | $887M | $1.1B | XXX | XXX | XXX |
| Gross Margin | 62% | 94% | XXX | XXX | XXX |
| EBITDA | $313M | $0.5M | XXX | XXX | XXX |
| EBITDA Margin | 22% | 0% | XXX | XXX | XXX |
| Net Profit | $185M | $325M | XXX | XXX | XXX |
| Net Margin | 13% | 28% | XXX | XXX | XXX |
| Net Debt | $0.8M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Shijiazhuang Yiling's stock price is CNY 13 (or $2).
Shijiazhuang Yiling has current market cap of CNY 22.5B (or $3.1B), and EV of CNY 22.8B (or $3.1B).
See Shijiazhuang Yiling trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.1B | $3.1B | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Shijiazhuang Yiling has market cap of $3.1B and EV of $3.1B.
Shijiazhuang Yiling's trades at 2.6x LTM EV/Revenue multiple, and 43.6x LTM EBITDA.
Analysts estimate Shijiazhuang Yiling's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Shijiazhuang Yiling and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.1B | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 6278.6x | XXX | XXX | XXX |
| P/E | -29.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpShijiazhuang Yiling's NTM/LTM revenue growth is 17%
Shijiazhuang Yiling's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Shijiazhuang Yiling's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Shijiazhuang Yiling's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Shijiazhuang Yiling and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -18% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -100% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 40% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shijiazhuang Yiling acquired XXX companies to date.
Last acquisition by Shijiazhuang Yiling was XXXXXXXX, XXXXX XXXXX XXXXXX . Shijiazhuang Yiling acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Shijiazhuang Yiling founded? | Shijiazhuang Yiling was founded in 2001. |
| Where is Shijiazhuang Yiling headquartered? | Shijiazhuang Yiling is headquartered in China. |
| Is Shijiazhuang Yiling publicy listed? | Yes, Shijiazhuang Yiling is a public company listed on SHE. |
| What is the stock symbol of Shijiazhuang Yiling? | Shijiazhuang Yiling trades under 002603 ticker. |
| When did Shijiazhuang Yiling go public? | Shijiazhuang Yiling went public in 2011. |
| Who are competitors of Shijiazhuang Yiling? | Similar companies to Shijiazhuang Yiling include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Shijiazhuang Yiling? | Shijiazhuang Yiling's current market cap is $3.1B |
| What is the current revenue of Shijiazhuang Yiling? | Shijiazhuang Yiling's last 12-month revenue is $1.2B. |
| What is the current EBITDA of Shijiazhuang Yiling? | Shijiazhuang Yiling's last 12-month EBITDA is $72.2M. |
| What is the current EV/Revenue multiple of Shijiazhuang Yiling? | Current revenue multiple of Shijiazhuang Yiling is 2.6x. |
| What is the current EV/EBITDA multiple of Shijiazhuang Yiling? | Current EBITDA multiple of Shijiazhuang Yiling is 43.6x. |
| What is the current revenue growth of Shijiazhuang Yiling? | Shijiazhuang Yiling revenue growth between 2023 and 2024 was -18%. |
| Is Shijiazhuang Yiling profitable? | Yes, Shijiazhuang Yiling is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
